New Metrics to Assess Type 2 Diabetes after Bariatric Surgery: The “Time-Within-Remission Range”
de Hollanda, Ana
Rubio, Miguel Ángel
Gregorio Oliva, José
Fernández-Soto, María Luisa
Ballesteros-Pomar, María D.
Morales, María José
Bueno Díez, Marta
de la Cruz, María José
Pereyra-García, Francisca María
López-Mezquita, Elena Teresa
Botana, Manuel Antonio
MetadataShow full item record
Almost one third of patients do not achieve type 2 diabetes remission after bariatric surgery or are unable to sustain this effect long term. Our objective was to delve further into the dynamic responses of diabetes after bariatric surgery and to evaluate the “time-within-remission range” as a variable of metabolic control. A descriptive cohort study was done using a computerised multicentre and multidisciplinary registry. All data were adjusted by propensity score. A total of 1186 subjects with a follow-up of 4.5 ± 2.5 years were included. Type of surgery, diabetes remission, recurrence of diabetes, “time-within-remission range” and key predictors of diabetes outcomes were assessed. All patients (70% women, 51.4 ± 9.2 years old, body mass index (BMI) 46.3 ± 6.9 kg/m2 ) underwent primary bariatric procedures. “Time-within-remission range” were 83.3% (33.3–91.6) after gastric bypass, 68.7% (7.1–87.5) after sleeve gastrectomy and 90% (83.3–92.8) after malabsorptive techniques (p < 0.001 for all). Duration of diabetes, baseline HbA1c and insulin treatment were significantly negatively correlated with the “time-within-remission range”. The association of bariatric techniques with “time-within-remission range”, using gastric bypass as a reference, were: odds ratio (OR) 3.70 (2.34–5.84), p < 0.001 for malabsorptive techniques and OR 0.55 (0.40–0.75), p < 0.001 for sleeve gastrectomy. Characteristics of type 2 diabetes powerfully influence the outcomes of bariatric surgery. The “time-within-remission range” unveils a superiority of gastric bypass compared to sleeve gastrectomy
Is part ofJournal of Clinical Medicine, 2020, vol. 9, núm. 4, p. 1070
European research projects
The following license files are associated with this item:
Except where otherwise noted, this item's license is described as cc-by (c) de Hollanda, Ana et al., 2020
Showing items related by title, author, creator and subject.
Genetic Testing to Predict Weight Loss and Diabetes Remission and Long-Term Sustainability after Bariatric Surgery: A Pilot Study Ciudin, Andreea; Fidilio, Enzamaria; Ortiz, Angel; Pich, Sara; Salas, Eduardo; Mesa, Jordi; Hernández, Cristina; Simó-Servat, Olga; Lecube Torelló, Albert (MDPI, 2019)Introduction: The aim of this pilot study was to assess genetic predisposition risk scores (GPS) in type 2 diabetic and non-diabetic patients in order to predict the better response to bariatric surgery (BS) in terms of ...
The role of morbid obesity in the promotion of metabolic disruptions and non-alcoholic steatohepatitis by Helicobacter Pylori Lecube Torelló, Albert; Valladares, Silvia; López Cano, Carolina; Gutiérrez Carrasquilla, Liliana; Ciudin, Andreea; Fort, José Manuel; Reñé Espinet, Josep Maria; Matias-Guiu, Xavier; Torres, Inés de; Bueno Díez, Marta; Pallares, Judit; Baena-Fustegueras, Juan A (Public Library of Science, 2016)Helicobacter pylory (HP) infection has been associated to an increased rate of type 2 diabetes (T2D) and liver disease through its effect on insulin resistance and systemic inflammation. However, results are inconstant ...
Global assessment of the impact of type 2 diabetes on sleep through specific questionnaires. A case-control study Lecube Torelló, Albert; Sánchez Peña, Enric; Gómez Peralta, Fernando; Abreu, Cristina; Valls Marsal, Joan; Mestre, Olga; Romero, Odile; Martínez González, María Dolores; Sampol, Gabriel; Ciudin, Andreea; Hernández, Cristina; Simó, Rafael (Public Library of Science, 2016)Type 2 diabetes (T2D) is an independent risk factor for sleep breathing disorders. However, it is unknown whether T2D affects daily somnolence and quality of sleep independently of the impairment of polysomnographic ...